Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-25-006653
Filing Date
2025-02-20
Accepted
2025-02-20 12:08:28
Documents
114
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ardx-20241231.htm   iXBRL 10-K 2344940
2 EX-19.1 ardx-20241231xex191.htm EX-19.1 79424
3 EX-23.1 ardx-20241231xex231.htm EX-23.1 7139
4 EX-31.1 ardx-20241231xex311.htm EX-31.1 9756
5 EX-31.2 ardx-20241231xex312.htm EX-31.2 9778
6 EX-32.1 ardx-20241231xex321.htm EX-32.1 6464
12 ardx-20241231_g1.jpg GRAPHIC 2931
  Complete submission text file 0001628280-25-006653.txt   11596316

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20241231.xsd EX-101.SCH 81622
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ardx-20241231_cal.xml EX-101.CAL 96645
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20241231_def.xml EX-101.DEF 397725
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20241231_lab.xml EX-101.LAB 913082
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20241231_pre.xml EX-101.PRE 670865
117 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20241231_htm.xml XML 1730470
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36485 | Film No.: 25644114
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)